• Veracyte director Robert S. Epstein sold 10,000 shares of common stock on May 20, 2026.
• The shares were sold at a weighted average price of USD 44.01.
• Epstein held 52,446 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001252004-26-000002), on May 22, 2026, and is solely responsible for the information contained therein.